| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 50,736 | 49,093 | 48,083 | 48,042 | | Cost of Revenue | 16,802 | 16,899 | 15,958 | 16,575 | | | Gross Profit | 33,934 | 32,194 | 32,125 | 31,467 | | | Operating Expenses | | Research Development | 8,666 | 8,935 | 8,537 | 8,109 | | Selling General and Administrative | 24,967 | 24,775 | 25,536 | 24,375 | | Non Recurring | 1,084 |
-
|
-
| 303 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 301 | (1,516) | (1,948) | (1,320) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 52 | 53 | 141 | 161 | | Earnings Before Interest And Taxes | (731) | (1,463) | (1,807) | (1,159) | | Interest Expense | 42 | 47 | 41 | 55 | | Income Before Tax | (773) | (1,510) | (1,848) | (1,214) | | Income Tax Expense | 329 | (1,397) | 237 | 1,214 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,102) | (113) | (2,085) | (2,428) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,102) | (113) | (2,085) | (2,428) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,102) | ($113) | ($2,085) | ($2,428) |
|
0.03% Nasdaq 
Income Statement
